Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Nautilus Biotechnology Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Nautilus Biotechnology Inc. June 13, 202497.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 17, 2026 | Schrodinger Inc. | Option exercise | +31,599 | $4.34 | $137,140 |
| Sep 17, 2026 | Schrodinger Inc. | Open-market sale | −10,000 | $28.00 | $280,000 |
| Sep 17, 2026 | Schrodinger Inc. | Open-market sale | −21,599 | $30.00 | $647,970 |
| Mar 5, 2026 | Schrodinger Inc. | Open-market sale | −1,366 | $12.90 | $17,621 |
| Mar 2, 2026 | Schrodinger Inc. | Grant or award | +24,250 | — | — |
| Mar 2, 2026 | Schrodinger Inc. | Grant or award | +6,077 | — | — |
| Mar 2, 2026 | Schrodinger Inc. | Grant or award | +27,576 | — | — |
| Mar 2, 2026 | Schrodinger Inc. | Open-market sale | −2,206 | $11.99 | $26,450 |
| Apr 14, 2025 | Schrodinger Inc. | Option exercise | +13,378 | $3.22 | $43,077 |
| Apr 14, 2025 | Schrodinger Inc. | Option exercise | +3,345 | $2.92 | $9,767 |
| Apr 14, 2025 | Schrodinger Inc. | Open-market sale | −8,378 | $25.11 | $210,372 |
| Apr 14, 2025 | Schrodinger Inc. | Open-market sale | −5,000 | $25.11 | $125,550 |
| Apr 14, 2025 | Schrodinger Inc. | Open-market sale | −3,345 | $25.00 | $83,625 |
| Mar 3, 2025 | Schrodinger Inc. | Grant or award | +15,625 | — | — |
Questions about Karen Akinsanya
What boards is Karen Akinsanya on?
Karen Akinsanya sits on the board of Nautilus Biotechnology Inc.
How long has Karen Akinsanya served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.